Ann: First Austria-based treatments utilising the OncoSil device, page-25

Leadership and Experience for Success

OncoSil, under CEO Nigel Lange, is well-positioned to make waves in the development and commercialization of oncology medical devices. Here's why this combination is considered potent:

• Experienced Leadership: Nigel Lange brings to the table a wealth of experience in the medical device and healthcare industry. Effective leadership is crucial for navigating the complex regulatory landscapes, securing investments, and driving the strategic direction necessary to bring innovative treatments to market.
• Sirtex Success Story: Many team members coming from Sirtex, a company known for its successful development and commercialisation of a novel radiotherapy device (SIR-Spheres) for treating liver cancer, bring invaluable experience. Their previous success with a similar technology (radioembolisation spheres) means they're already familiar with the challenges and opportunities in the field of targeted radiation therapy.
• Specialised Expertise: The technical and clinical development of medical devices, especially in the field of oncology, requires specialised expertise. Team members with a background in successfully bringing a medical device through the rigorous processes of clinical trials, regulatory approval, and market entry are a significant asset.
• Strategic Vision: The combination of Nigel Lange’s leadership and the team's experience from Sirtex provides OncoSil with a strategic vision rooted in a deep understanding of the oncology market and the specific challenges of developing and commercialising medical devices in this sector.
• Network and Relationships: Success in the medical device industry is not just about the product; it's also about the relationships with regulatory bodies, healthcare professionals, and institutions. The OncoSil team, enriched with individuals who have navigated these waters before, brings a network of relationships that can accelerate clinical trials, approval processes, and adoption by healthcare providers.
• Market Insight: Understanding the needs of patients, healthcare providers, and the dynamics of the healthcare market is crucial. The team's prior experience provides them with insights into market needs, competitive positioning, and the ability to adapt their strategy to meet regulatory, technological, and market changes.
• Commitment to Innovation: A team that has been part of a success story like Sirtex’s is likely to be highly motivated and committed to innovation. This drive is crucial in the face of the inevitable challenges of developing new medical treatments.

In sum, the leadership of Nigel Lange, combined with the team's expertise and experience from Sirtex, gives OncoSil a strong foundation to overcome the hurdles of medical device development in oncology. Their combined expertise not only in the technical and clinical aspects but also in navigating the regulatory and market challenges, positions OncoSil for a promising future in improving cancer treatment outcomes. - Do your own research, ask your fin. adviser as always.